DEF: Helius Medical Technologies Seeks Stockholder Approval for Reverse Stock Split and Warrant Issuance to Maintain Nasdaq Listing

Helius Medical Technologies is asking stockholders to approve a reverse stock split and the issuance of shares upon warrant exercises to comply with Nasdaq listing requirements at its upcoming annual meeting.

Summary

• Helius Medical Technologies is holding its 2025 Annual Meeting of Stockholders on April 21, 2025.
• Stockholders will vote on several proposals, including the election of six directors, ratification of the appointment of Baker Tilly US, LLP as the independent registered public accounting firm, and approval of the issuance of up to 6,213,888 shares of common stock upon the exercise of existing warrants.
• A key proposal involves an amendment to the Certificate of Incorporation to effect a reverse stock split of the Class A common stock at a ratio of 1 for 2 to 1 for 30, to be determined by the Board of Directors.
• This reverse stock split aims to enable the company to comply with Nasdaq's continued listing requirements.
• Another proposal seeks authorization to adjourn the Annual Meeting to solicit additional proxies if there are insufficient votes to approve the warrant issuance or reverse stock split proposals.
• The Board of Directors unanimously recommends voting FOR all director nominees and FOR Proposals 2, 3, 4, and 5.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company is taking proactive steps to address its Nasdaq listing deficiency, the need for a reverse stock split and warrant inducement offer suggests underlying financial challenges. The Board's recommendation to vote FOR all proposals indicates a belief in the company's plan, but the risks associated with delisting and potential negative market perception temper the overall outlook.

Positives

• The proposed reverse stock split aims to maintain the company's listing on the Nasdaq Capital Market, which the Board believes is in the best interest of the company and its stockholders.
• Approval of the warrant issuance could provide the company with additional capital.
• The Board is actively addressing the Nasdaq's minimum bid price requirement.

Negatives

• The company is currently not in compliance with the Nasdaq's minimum bid price requirement.
• A reverse stock split could be perceived negatively by some investors.
• If the company fails to regain compliance with Nasdaq listing rules, it could face delisting, which could negatively impact the stock price and the company's ability to raise capital.

Risks

• Failure to obtain stockholder approval for the reverse stock split or warrant issuance could hinder the company's ability to comply with Nasdaq listing requirements.
• Delisting from Nasdaq could negatively impact the stock price and the company's ability to raise capital.
• A reverse stock split may not be sufficient to maintain compliance with Nasdaq listing requirements.
• The company's common stock may be deemed a penny stock if it is delisted from Nasdaq, making transactions more difficult.

Future Outlook

The company intends to regain compliance with Nasdaq listing requirements through the proposed reverse stock split and other measures. The company expects to require additional financing to fund its ongoing activities.

Management Comments

• The Board of Directors unanimously recommends that you vote FOR the election of each director nominee and FOR Proposals 2, 3, 4 and 5.

Industry Context

Reverse stock splits are often used by companies facing delisting from major exchanges to increase their stock price and regain compliance with listing requirements. The warrant inducement offer is a common tactic to encourage warrant holders to exercise their warrants, providing the company with immediate capital.

Comparison to Industry Standards

• Reverse stock splits are a relatively common strategy for companies facing delisting, although their success varies depending on the company's underlying financial health and market conditions.
• Comparable companies that have recently undertaken reverse stock splits include [hypothetical company A] and [hypothetical company B], although their specific circumstances and results may differ.
• Warrant inducement offers are also a standard practice, with terms and conditions varying based on the company's needs and the warrants' existing terms.

Stakeholder Impact

• Shareholders may experience dilution if the warrant issuance is approved and the warrants are exercised.
• Shareholders may see a change in the stock price and marketability of their shares as a result of the reverse stock split.
• Employees may be affected by the company's ability to maintain its Nasdaq listing and raise capital.
• The company's ability to execute its business plan and deliver value to stakeholders depends on the successful implementation of these proposals.

Next Steps

• Stockholders will vote on the proposals at the Annual Meeting on April 21, 2025.
• The Board will determine the specific reverse stock split ratio and timing if the proposal is approved.
• The company will file the Reverse Stock Split Certificate of Amendment with the Secretary of State of the State of Delaware if the Board decides to implement the reverse stock split.
• The company will continue to work towards regaining compliance with Nasdaq listing requirements.

Key Dates

Keywords

reverse stock split, warrant issuance, Nasdaq listing, stockholder approval, annual meeting, Helius Medical Technologies, compliance